| Dr. Suppes reported receiving grants and research support from Abbott, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, JDS Pharmaceutical, Janssen, National Institutes of Mental Health, Novartis Pharmaceuticals, The Stanley Medical Research Institute and Wyeth/Solvay. She also reported having served as a consultant or on the advisory board for Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Company, Janssen, JDS Pharmaceuticals, GlaxoSmithKline, Novartis Pharmaceuticals, Ortho-McNeil Pharmaceutical, Pfizer, Shire Pharmaceutical, UCB Pharma, and Wyeth/Solvay. |
Primary source: U.S. Psychiatric and Mental Health Congress regional extension
Source reference: Suppes T "Managing Mixed Mania: Diagnostic Dilemmas and Therapeutic Challenges" USPSYCH regional extension 2007.
